Saliva test upstart Rako Science sold to rival APHG

Saliva test upstart Rako Science sold to rival APHG
Rako Science partnered with Waipareira Trust to provide covid saliva testing for Māori. (Image: NZME)
Pattrick Smellie
Today’s announcement of the sale of saliva-testing firm Rako Science to what was once its arch-rival, Asia Pacific Healthcare Group (APHG), is a classic case of the old adage: “If you can’t beat 'em, join 'em”.For more than a year at the height of the covid lockdowns, Rako and APHG were at one another’s throats both in public and behind-the-scenes as Rako aggressively pressed the case for national uptake of its novel saliva test technology.Rako’s main target was the health ministry, which appeared to...

More Opinion

NZSA: fighting for shareholders
Markets

Oliver Mander: NZSA: fighting for shareholders

CEO pushes back at criticism its 'lost its way'.

Councils’ innovation dilemma
Opinion

Peter Griffin: Councils’ innovation dilemma

Our major cities still have the ingredients to be tech talent and investment centres.

KiwiSaver is leaking
Opinion

David Chaplin: KiwiSaver is leaking

If KiwiSaver keeps drifting away from its purpose, it might as well not exist at all.

David Chaplin 26 Aug 2025
The Macro Series: NZ's North Star
Opinion

Simon Robertson: The Macro Series: NZ's North Star

NZ's huge advantage is that it is not in the business of heavy manufacturing.

Simon Robertson 23 Aug 2025